280 related articles for article (PubMed ID: 35993516)
1. Procoagulant platelets: novel players in thromboinflammation.
Denorme F; Campbell RA
Am J Physiol Cell Physiol; 2022 Oct; 323(4):C951-C958. PubMed ID: 35993516
[TBL] [Abstract][Full Text] [Related]
2. TMEM16F-Mediated Platelet Membrane Phospholipid Scrambling Is Critical for Hemostasis and Thrombosis but not Thromboinflammation in Mice-Brief Report.
Baig AA; Haining EJ; Geuss E; Beck S; Swieringa F; Wanitchakool P; Schuhmann MK; Stegner D; Kunzelmann K; Kleinschnitz C; Heemskerk JW; Braun A; Nieswandt B
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2152-2157. PubMed ID: 27634832
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 patients exhibit reduced procoagulant platelet responses.
Denorme F; Manne BK; Portier I; Petrey AC; Middleton EA; Kile BT; Rondina MT; Campbell RA
J Thromb Haemost; 2020 Nov; 18(11):3067-3073. PubMed ID: 32945081
[TBL] [Abstract][Full Text] [Related]
4. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets.
Sinauridze EI; Kireev DA; Popenko NY; Pichugin AV; Panteleev MA; Krymskaya OV; Ataullakhanov FI
Thromb Haemost; 2007 Mar; 97(3):425-34. PubMed ID: 17334510
[TBL] [Abstract][Full Text] [Related]
5. Platelets and coagulation in thrombus formation: aberrations in the Scott syndrome.
van Geffen JP; Swieringa F; Heemskerk JW
Thromb Res; 2016 May; 141 Suppl 2():S12-6. PubMed ID: 27207414
[TBL] [Abstract][Full Text] [Related]
6. Inner Mitochondrial Membrane Disruption Links Apoptotic and Agonist-Initiated Phosphatidylserine Externalization in Platelets.
Choo HJ; Kholmukhamedov A; Zhou C; Jobe S
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1503-1512. PubMed ID: 28663253
[TBL] [Abstract][Full Text] [Related]
7. Persistence of procoagulant surface expression on activated human platelets: involvement of apoptosis and aminophospholipid translocase activity.
Leung R; Gwozdz AM; Wang H; Bang KW; Packham MA; Freedman J; Rand ML
J Thromb Haemost; 2007 Mar; 5(3):560-70. PubMed ID: 17155950
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood.
French SL; Arthur JF; Lee H; Nesbitt WS; Andrews RK; Gardiner EE; Hamilton JR
J Thromb Haemost; 2016 Aug; 14(8):1642-54. PubMed ID: 26878340
[TBL] [Abstract][Full Text] [Related]
9. Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity.
Jun EA; Lim KM; Kim K; Bae ON; Noh JY; Chung KH; Chung JH
Nanotoxicology; 2011 Jun; 5(2):157-67. PubMed ID: 20822370
[TBL] [Abstract][Full Text] [Related]
10. Procoagulant platelets and the pathways leading to cell death.
Hua VM; Chen VM
Semin Thromb Hemost; 2015 Jun; 41(4):405-12. PubMed ID: 26035696
[TBL] [Abstract][Full Text] [Related]
11. The mitochondrial calcium uniporter regulates procoagulant platelet formation.
Kholmukhamedov A; Janecke R; Choo HJ; Jobe SM
J Thromb Haemost; 2018 Nov; 16(11):2315-2321. PubMed ID: 30179298
[TBL] [Abstract][Full Text] [Related]
12. Diannexin, an annexin A5 homodimer, binds phosphatidylserine with high affinity and is a potent inhibitor of platelet-mediated events during thrombus formation.
Rand ML; Wang H; Pluthero FG; Stafford AR; Ni R; Vaezzadeh N; Allison AC; Kahr WH; Weitz JI; Gross PL
J Thromb Haemost; 2012 Jun; 10(6):1109-19. PubMed ID: 22463102
[TBL] [Abstract][Full Text] [Related]
13. Platelet ACKR3/CXCR7 favors antiplatelet lipids over an atherothrombotic lipidome and regulates thromboinflammation.
Cebo M; Dittrich K; Fu X; Manke MC; Emschermann F; Rheinlaender J; von Eysmondt H; Ferreirós N; Sudman J; Witte A; Pelzl L; Borst O; Geisler T; Rath D; Bakchoul T; Gawaz M; Schäffer TE; Lämmerhofer M; Chatterjee M
Blood; 2022 Mar; 139(11):1722-1742. PubMed ID: 34905596
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of calcium spiking, mitochondrial collapse and phosphatidylserine exposure in platelet subpopulations during activation.
Obydennyy SI; Sveshnikova AN; Ataullakhanov FI; Panteleev MA
J Thromb Haemost; 2016 Sep; 14(9):1867-81. PubMed ID: 27343487
[TBL] [Abstract][Full Text] [Related]
15. Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms.
Marin Oyarzún CP; Heller PG
Front Immunol; 2019; 10():1373. PubMed ID: 31258539
[TBL] [Abstract][Full Text] [Related]
16. Consensus report on markers to distinguish procoagulant platelets from apoptotic platelets: communication from the Scientific and Standardization Committee of the ISTH.
Josefsson EC; Ramström S; Thaler J; Lordkipanidzé M;
J Thromb Haemost; 2023 Aug; 21(8):2291-2299. PubMed ID: 37172731
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms Underlying Dichotomous Procoagulant COAT Platelet Generation-A Conceptual Review Summarizing Current Knowledge.
Veuthey L; Aliotta A; Bertaggia Calderara D; Pereira Portela C; Alberio L
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269679
[TBL] [Abstract][Full Text] [Related]
18. Platelet-inspired nanomedicine in hemostasis thrombosis and thromboinflammation.
Raghunathan S; Rayes J; Sen Gupta A
J Thromb Haemost; 2022 Jul; 20(7):1535-1549. PubMed ID: 35435322
[TBL] [Abstract][Full Text] [Related]
19. Sodium-Calcium Exchanger Reverse Mode Sustains Dichotomous Ion Fluxes Required for Procoagulant COAT Platelet Formation.
Aliotta A; Bertaggia Calderara D; Zermatten MG; Alberio L
Thromb Haemost; 2021 Mar; 121(3):309-321. PubMed ID: 33099282
[TBL] [Abstract][Full Text] [Related]
20. Enhanced procoagulant activity of platelets after chemotherapy in non-small cell lung cancer.
Ma R; Bi Y; Kou J; Zhou J; Shi J
Cancer Biol Ther; 2017 Aug; 18(8):627-634. PubMed ID: 28718695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
